Free Trial
NASDAQ:ADXN

Addex Therapeutics (ADXN) Stock Price, News & Analysis

Addex Therapeutics logo
$7.86 -0.87 (-9.97%)
As of 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Addex Therapeutics Stock (NASDAQ:ADXN)

Key Stats

Today's Range
$7.90
$7.90
50-Day Range
$7.54
$9.58
52-Week Range
$6.51
$13.27
Volume
485 shs
Average Volume
884 shs
Market Capitalization
$8.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Consensus Rating
Buy

Company Overview

Addex Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

ADXN MarketRank™: 

Addex Therapeutics scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Addex Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Addex Therapeutics has received no research coverage in the past 90 days.

  • Read more about Addex Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Addex Therapeutics is -23.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Addex Therapeutics is -23.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Addex Therapeutics has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Addex Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    0.15% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Addex Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Addex Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.15% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Sentiment

    Addex Therapeutics has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Addex Therapeutics this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Addex Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.00% of the stock of Addex Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 16.14% of the stock of Addex Therapeutics is held by institutions.

  • Read more about Addex Therapeutics' insider trading history.
Receive ADXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADXN Stock News Headlines

Addex Therapeutics Ltd (ADXN) - Yahoo Finance
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
See More Headlines

ADXN Stock Analysis - Frequently Asked Questions

Addex Therapeutics' stock was trading at $7.00 at the beginning of the year. Since then, ADXN shares have increased by 14.9% and is now trading at $8.0450.

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) announced its quarterly earnings data on Friday, November, 22nd. The company reported ($2.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.40) by $1.37. Addex Therapeutics had a negative trailing twelve-month return on equity of 54.27% and a net margin of 3,584.49%.
Read the conference call transcript
.

Shares of Addex Therapeutics reverse split on Monday, October 23rd 2023.The 1-20 reverse split was announced on Monday, October 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ADXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Addex Therapeutics investors own include Arista Networks (ANET), Adobe (ADBE), NVIDIA (NVDA), Broadcom (AVGO), GE Aerospace (GE), Vista Energy (VIST) and Arch Capital Group (ACGL).

Company Calendar

Last Earnings
11/22/2024
Today
8/29/2025
Next Earnings (Estimated)
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXN
CIK
1574232
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$30.00
Potential Upside/Downside
+272.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.02 million
Net Margins
3,584.49%
Pretax Margin
-2,307.03%
Return on Equity
-54.27%
Return on Assets
-49.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.02
Quick Ratio
3.02

Sales & Book Value

Annual Sales
$170.62 thousand
Price / Sales
49.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.37 per share
Price / Book
0.78

Miscellaneous

Outstanding Shares
1,060,000
Free Float
901,000
Market Cap
$8.53 million
Optionable
Not Optionable
Beta
1.63

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ADXN) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners